- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
C9orf89 Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP18337a | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP18337a-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
C9orf89 Antibody (N-term) - Product info | |
| Application | WB
|
| Primary Accession | Q96LW7 |
| Other Accession | Q9D1I2, NP_115686.3 |
| Reactivity | Human |
| Predicted | Mouse |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 25589 Da |
C9orf89 Antibody (N-term) - Additional info | |
| Gene ID 84270 | |
| Other Names C9orf89; Bcl10-interacting CARD protein | |
| Target/Specificity This C9orf89 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 30-59 amino acids from the N-terminal region of human C9orf89. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions C9orf89 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
C9orf89 Antibody (N-term) - Protein Information | |
| Name C9orf89 | |
| Function Plays a role in inhibiting the effects of BCL10-induced activation of NF-kappa-B. May inhibit the phosphorylation of BCL10 in a CARD-dependent manner | |
| Cellular Location Nucleus. Note=Co-expression with BCL10 induced translocation from nucleus to cytosol | |
| Tissue Location Expressed in ovary, testis, placenta, skeletal muscle, kidney, lung, heart and liver (at protein level) Expressed in thymus and brain | |
C9orf89 Antibody (N-term) - Related products
C9orf89 Antibody (N-term) - Application data
-
C9orf89 Antibody (N-term) (Cat. #AP18337a) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the C9orf89 Antibody detected the C9orf89 protein (arrow).
C9orf89 Antibody (N-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
C9orf89 plays a role in inhibiting the effects of BCL10-induced activation of NF-kappa-B. May inhibit the phosphorylation of BCL10 in a CARD-dependent manner.
REFERENCES
Matsuoka, S., et al. Science 316(5828):1160-1166(2007) Woo, H.N., et al. FEBS Lett. 578(3):239-244(2004)